Tarek Alhamad

The outcomes of simultaneous liver and kidney transplantation using donation after cardiac death organs.

Utilization of donors after cardiac death organs for simultaneous liver and kidney transplantation.

Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.

Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation.

Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.

Survival implications of opioid use before and after liver transplantation.

Transplant Center Volume and the Risk of Pancreas Allograft Failure.

The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation.

Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy.

Reexamining the Association of Body Mass Index With Overall Survival Outcomes After Liver Transplantation.

Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice.

An economic assessment of contemporary kidney transplant practice.

ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation.

Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis.

Safety and efficacy of patiromer use with tacrolimus in kidney transplant recipients.

The association of preoperative cardiac stress testing with 30-day death and myocardial infarction among patients undergoing kidney transplantation.

Racial/Ethnic Disparities in Access and Outcomes of Simultaneous Liver-Kidney Transplant Among Liver Transplant Candidates With Renal Dysfunction in the United States.

Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes.

Center-Related Variation in Cardiac Stress Testing in the 18 Months Prior to Renal Transplantation.

Poor Outcomes With the Use of Checkpoint Inhibitors in Kidney Transplant Recipients.

Three-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation in type 2 diabetes patients.

Talimogene Laherparepvec Use in Kidney Transplant Recipient.

Economic impacts of alternative kidney transplant immunosuppression: A national cohort study.

An overview of frailty in kidney transplantation: measurement, management and future considerations.

Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients.

CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder.

Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.

Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.

Solid organ transplantation during the COVID-19 pandemic in the United States.

Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort.

Pancreas transplantation perceptions and practice: Results from a national US survey.

Association of Ambient Fine Particulate Matter Air Pollution With Kidney Transplant Outcomes.

Utility of Donor-Derived Cell-Free DNA in Detecting ABMR in Patients With AT1R Antibodies.

International Practices on COVID-19 Vaccine Mandates for Transplant Candidates.

Comprehensive review: Frailty in pancreas transplant candidates and recipients.

COVID-19 Vaccination Status and Operative Outcomes after Kidney Transplantation.

The association of center volume with transplant outcomes in selected high-risk groups in kidney transplantation.

The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications.

Patterns in Use and Transplant Outcomes Among Adult Recipients of Kidneys From Deceased Donors With COVID-19.

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation.

Kidney Transplant Clinicians' Perceptions of Palliative Care for Patients With Failing Allografts in the US: A Mixed Methods Study.

Donor-derived cell free DNA as a biomarker in kidney transplantation.

Recurrent atypical antiglomerular basement membrane nephritis in the kidney transplant.

Kidney Transplantation from SARS-CoV-2-Infected Deceased Donors: Comfort or Caution in Contemporary Practice?

Indications, Techniques, and Barriers for Pancreas Transplant Biopsy: A Consensus Perspective From a Survey of US Centers.

Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians.

Cell-Free DNA for the detection of kidney allograft rejection.